Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation

by Imco Sibum, Paul Hagedoorn, Henderik W. Frijlink, Floris Grasmeijer
Published 2019-05-01

Correction: Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation

by Floris Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink, H. Anne de Boer
Published 2013-01-01

Drug content effects on the dispersion performance of adhesive mixtures for inhalation.

by Floris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, Anne H de Boer
Published 2013-01-01

Correction: Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation.

by Floris Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink, H. Anne de Boer
Published 2013-01-01

Mixing time effects on the dispersion performance of adhesive mixtures for inhalation.

by Floris Grasmeijer, Paul Hagedoorn, Henderik W Frijlink, H Anne de Boer
Published 2013-01-01

Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops^® High Dose Dry Powder Inhalation Device While Maintaining Dispersibility

by Imco Sibum, Paul Hagedoorn, Carel O. Botterman, Henderik W. Frijlink, Floris Grasmeijer
Published 2020-07-01

A user-friendly model for spray drying to aid pharmaceutical product development.

by Niels Grasmeijer, Hans de Waard, Wouter L J Hinrichs, Henderik W Frijlink
Published 2013-01-01

Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease

by Bahez Gareb, Antonius T. Otten, Henderik W. Frijlink, Gerard Dijkstra, Jos G. W. Kosterink
Published 2020-06-01

Prerequisites for a dry powder inhaler for children with cystic fibrosis.

by Anne J Lexmond, Paul Hagedoorn, Henderik W Frijlink, Bart L Rottier, Anne H de Boer
Published 2017-01-01

Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with <span style="font-variant: small-caps">L</span>-Leucine or Trileuci...

by Imco Sibum, Paul Hagedoorn, Markus P. G. Kluitman, Martijn Kloezen, Henderik W. Frijlink, Floris Grasmeijer
Published 2019-12-01

Stability of lysozyme in aqueous extremolyte solutions during heat shock and accelerated thermal conditions.

by Christina Avanti, Vinay Saluja, Erwin L P van Streun, Henderik W Frijlink, Wouter L J Hinrichs
Published 2014-01-01

Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions

by Mitchel J.R. Ruigrok, Henderik W. Frijlink, Barbro N. Melgert, Peter Olinga, Wouter L.J. Hinrichs
Published 2021-03-01

Effect of inhaler design variables on paediatric use of dry powder inhalers.

by Anne J Lexmond, Tonnis J Kruizinga, Paul Hagedoorn, Bart L Rottier, Henderik W Frijlink, Anne H de Boer
Published 2014-01-01

Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus

by Yoshita Bhide, Jasmine Tomar, Wei Dong, Jacqueline de Vries-Idema, Henderik W. Frijlink, Anke Huckriede, Wouter L. J. Hinrichs
Published 2018-01-01

The Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for Production.

by Gaurav Kanojia, Rimko Ten Have, Arjen Bakker, Koen Wagner, Henderik W Frijlink, Gideon F A Kersten, Jean-Pierre Amorij
Published 2016-01-01

Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems

by Annemarie Broesder, Julia M. E. Berends, Sophie M. Scheepers, Duong N. Nguyen, Henderik W. Frijlink, Wouter L. J. Hinrichs
Published 2021-05-01

Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process

by Bahez Gareb, Silke Posthumus, Max Beugeling, Pauline Koopmans, Daan J. Touw, Gerard Dijkstra, Jos G.W. Kosterink, Henderik W. Frijlink
Published 2019-08-01

New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalation.

by Floris Grasmeijer, Anne J Lexmond, Maarten van den Noort, Paul Hagedoorn, Anthony J Hickey, Henderik W Frijlink, Anne H de Boer
Published 2014-01-01

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation

by Harshad P. Patil, José Herrera Rodriguez, Jacqueline de Vries-Idema, Tjarko Meijerhof, Henderik W. Frijlink, Wouter L. J. Hinrichs, Anke Huckriede
Published 2017-07-01

Development of an Orodispersible Film Containing Stabilized Influenza Vaccine

by Yu Tian, Yoshita C. Bhide, Herman J. Woerdenbag, Anke L. W. Huckriede, Henderik W. Frijlink, Wouter L. J. Hinrichs, J. Carolina Visser
Published 2020-03-01